| Filing Date | Insider | Type | 10b5-1 | Net Shares | Ownership change | Avg. Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-06-01 | Cambrian BioPharma Inc 10% Owner | Sale | -25,000 | -16.11%130,142 | $20.02 | $500,543 | View SEC filing | |
| 2026-06-01 | Peyer James 10% Owner, Other | Sale | -25,000 | -16.11%130,142 | $20.02 | $500,543 | View SEC filing | |
| 2025-12-10 | Cambrian BioPharma Inc 10% Owner | Sale | -6,612 | -3.85%155,142 | $8.25 | $54,575 | View SEC filing | |
| 2025-12-10 | Peyer James 10% Owner, Other | Sale | -6,612 | -3.85%155,142 | $8.25 | $54,575 | View SEC filing | |
| 2025-12-08 | Cambrian BioPharma Inc 10% Owner | Sale | -21,295 | -11.66%161,359 | $10.93 | $232,690 | View SEC filing | |
| 2025-12-08 | Peyer James 10% Owner, Other | Sale | -21,295 | -11.66%161,359 | $10.93 | $232,690 | View SEC filing | |
| 2023-09-13 | Celebi John President and CEO | Purchase | +500 | +0.45%111,311 | $0.85 | $425 | View SEC filing | |
| 2023-06-02 | Presight Sensei Co-Invest Fund, L.P. Other | Sale | -3,441,661 | -100.00%0 | $1.58 | $5,437,824 | View SEC filing | |
| 2023-02-27 | Presight Sensei Co-Invest Fund, L.P. Other | Purchase | +2,200 | +0.09%2,485,923 | $1.61 | $3,539 | View SEC filing | |
| 2022-06-10 | Peyer James Director, 10% Owner | Purchase | +1,203 | +0.02%5,231,488 | $3.20 | $3,850 | View SEC filing | |
| 2022-06-10 | Cambrian BioPharma Inc 10% Owner | Purchase | +1,203 | +0.02%5,231,488 | $3.20 | $3,850 | View SEC filing | |
| 2022-04-21 | Peyer James Director, 10% Owner | Purchase | +9,500 | +0.20%4,798,293 | $14.34 | $136,230 | View SEC filing | |
| 2022-04-21 | Peyer James Director, 10% Owner | Purchase | +752 | +0.02%4,690,905 | $19.75 | $14,852 | View SEC filing | |
| 2022-04-21 | Cambrian BioPharma Inc 10% Owner | Purchase | +9,500 | +0.20%4,798,293 | $14.34 | $136,230 | View SEC filing | |
| 2022-04-21 | Cambrian BioPharma Inc 10% Owner | Purchase | +752 | +0.02%4,690,905 | $19.75 | $14,852 | View SEC filing | |
| 2022-03-02 | Cambrian BioPharma Inc 10% Owner | Purchase | +1,203 | +0.02%5,231,989 | $3.20 | $3,850 | View SEC filing | |
| 2022-03-02 | Peyer James Director, 10% Owner | Purchase | +1,203 | +0.02%5,231,989 | $3.20 | $3,850 | View SEC filing | |
| 2022-03-01 | Peyer James Director, 10% Owner | Purchase | +2,500 | +0.05%5,230,786 | $3.60 | $9,000 | View SEC filing | |
| 2022-03-01 | Cambrian BioPharma Inc 10% Owner | Purchase | +2,500 | +0.05%5,230,786 | $3.60 | $9,000 | View SEC filing | |
| 2022-02-28 | Peyer James Director, 10% Owner | Purchase | +2,500 | +0.05%5,228,286 | $3.65 | $9,125 | View SEC filing | |
| 2022-02-28 | Cambrian BioPharma Inc 10% Owner | Purchase | +2,500 | +0.05%5,228,286 | $3.65 | $9,125 | View SEC filing | |
| 2022-02-24 | Cambrian BioPharma Inc 10% Owner | Purchase | +17,500 | +0.34%5,225,786 | $3.65 | $63,950 | View SEC filing | |
| 2022-02-24 | Peyer James Director, 10% Owner | Purchase | +17,500 | +0.34%5,225,786 | $3.65 | $63,950 | View SEC filing | |
| 2022-02-22 | Peyer James Director, 10% Owner | Purchase | +19,949 | +0.38%5,208,286 | $4.02 | $80,187 | View SEC filing | |
| 2022-02-22 | Cambrian BioPharma Inc 10% Owner | Purchase | +19,949 | +0.38%5,208,286 | $4.02 | $80,187 | View SEC filing |
1-25 of 107
